0001179110-22-000454.txt : 20220112
0001179110-22-000454.hdr.sgml : 20220112
20220112163152
ACCESSION NUMBER: 0001179110-22-000454
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211222
FILED AS OF DATE: 20220112
DATE AS OF CHANGE: 20220112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Downing Philip A
CENTRAL INDEX KEY: 0001576819
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23357
FILM NUMBER: 22526925
MAIL ADDRESS:
STREET 1: C/O BIOANALYTICAL SYSTEMS, INC.
STREET 2: 2701 KENT AVENUE
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inotiv, Inc.
CENTRAL INDEX KEY: 0000720154
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 351345024
STATE OF INCORPORATION: IN
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 2701 KENT AVE
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906-1382
BUSINESS PHONE: 3174634527
MAIL ADDRESS:
STREET 1: 2701 KENT AVENUE
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906-1382
FORMER COMPANY:
FORMER CONFORMED NAME: BIOANALYTICAL SYSTEMS INC
DATE OF NAME CHANGE: 19970918
4/A
1
edgar.xml
FORM 4/A -
X0306
4/A
2021-12-22
2021-12-30
0
0000720154
Inotiv, Inc.
NOTV
0001576819
Downing Philip A
C/O INOTIV, INC.
2701 KENT AVENUE
WEST LAFAYETTE
IN
47906
0
1
0
0
Sr. VP, Preclinical Srvcs.
Common Shares
2021-12-22
4
S
0
3057
43.0412
D
40195
D
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.01 to $43.115, inclusive, to cover taxes related to the vesting of restricted stock awards. The reporting person undertakes to provide to Inotiv, Inc., any security holder of Inotiv, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This amendment is being filed solely for the purpose of correcting and supplementing the language of Footnote 1 to the original filing. Footnote 1 to the original filing described the transaction as a purchase when it was, in fact, a sale. The Footnote has also been modified to clarify that the sale was made to cover taxes related to the vesting of restricted stock awards.
/s/ Beth Taylor, attorney-in-fact for Philip A. Downing
2022-01-12